Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00254891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
International, Randomized, Open-Label, Phase 3 Trial of Paclitaxel/Carboplatin Plus PF-3512676 Versus Paclitaxel/Carboplatin Alone as First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of PF-3512676 administered in combination with paclitaxel/carboplatin chemotherapy as first-line treatment in patients with locally advanced or metastatic Non-Small-Cell Lung Cancer (NSCLC) and to compare it to the efficacy and safety of paclitaxel
Study identification
- NCT ID
- NCT00254891
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 828 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2005 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Jul 2008 (Actual)
- Last update posted
- Mar 30, 2015
2005 – 2008
United States locations
- U.S. sites
- 89
- U.S. states
- 28
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Little Rock | Alaska | 72205 | — |
| Pfizer Investigational Site | Hot Springs | Arkansas | 71913 | — |
| Pfizer Investigational Site | Chula Vista | California | 91911 | — |
| Pfizer Investigational Site | La Mesa | California | 91942 | — |
| Pfizer Investigational Site | Oceanside | California | 92056 | — |
| Pfizer Investigational Site | Palm Springs | California | 92262-4885 | — |
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | San Francisco | California | 94115 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30306 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30308 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30322 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Fayetteville | Georgia | 30214 | — |
| Pfizer Investigational Site | Macon | Georgia | 31217 | — |
| Pfizer Investigational Site | Marietta | Georgia | 30060 | — |
| Pfizer Investigational Site | Tucker | Georgia | 30084 | — |
| Pfizer Investigational Site | Rockford | Illinois | 61104 | — |
| Pfizer Investigational Site | Jefferson | Indiana | 47130 | — |
| Pfizer Investigational Site | New Albany | Indiana | 47150-6809 | — |
| Pfizer Investigational Site | Cedar Rapids | Iowa | 52403 | — |
| Pfizer Investigational Site | Dubuque | Iowa | 52001 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40503 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40202 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40217 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40241 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40505-4816 | — |
| Pfizer Investigational Site | Shelbyville | Kentucky | 40065 | — |
| Pfizer Investigational Site | Covington | Louisiana | 70433 | — |
| Pfizer Investigational Site | Gretna | Louisiana | 70056 | — |
| Pfizer Investigational Site | Lafayette | Louisiana | 70503 | — |
| Pfizer Investigational Site | Marrero | Louisiana | 70006 | — |
| Pfizer Investigational Site | Marrero | Louisiana | 70072 | — |
| Pfizer Investigational Site | Metairie | Louisiana | 70006 | — |
| Pfizer Investigational Site | New Orleans | Louisiana | 70115 | — |
| Pfizer Investigational Site | Biddeford | Maine | 04005 | — |
| Pfizer Investigational Site | Brunswick | Maine | 04011 | — |
| Pfizer Investigational Site | Scarborough | Maine | 04074 | — |
| Pfizer Investigational Site | Worcester | Massachusetts | 01608 | — |
| Pfizer Investigational Site | Allegan | Michigan | 49010 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48109-0848 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48109 | — |
| Pfizer Investigational Site | Kalamazoo | Michigan | 49007 | — |
| Pfizer Investigational Site | Kalamazoo | Michigan | 49048 | — |
| Pfizer Investigational Site | Saint Joseph | Michigan | 49085 | — |
| Pfizer Investigational Site | Columbus | Mississippi | 39705 | — |
| Pfizer Investigational Site | Corinth | Mississippi | 38834 | — |
| Pfizer Investigational Site | Tupelo | Mississippi | 38801 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68114 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68124 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68130 | — |
| Pfizer Investigational Site | Papillion | Nebraska | 68046 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89102 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89106 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87109 | — |
| Pfizer Investigational Site | Ruidoso | New Mexico | 88345 | — |
| Pfizer Investigational Site | Buffalo | New York | 14263 | — |
| Pfizer Investigational Site | Great Neck | New York | 11023 | — |
| Pfizer Investigational Site | Asheville | North Carolina | 28801 | — |
| Pfizer Investigational Site | Brevard | North Carolina | 28712 | — |
| Pfizer Investigational Site | Lexington | North Carolina | 27292 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Canton | Ohio | 44718 | — |
| Pfizer Investigational Site | Dover | Ohio | 44622 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112-4491 | — |
| Pfizer Investigational Site | Portland | Oregon | 97227-1191 | — |
| Pfizer Investigational Site | Langhorne | Pennsylvania | 19047 | — |
| Pfizer Investigational Site | Chattanooga | Tennessee | 37404-3324 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38120 | — |
| Pfizer Investigational Site | Arlington | Texas | 76012 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230 | — |
| Pfizer Investigational Site | Dallas | Texas | 75235-7786 | — |
| Pfizer Investigational Site | Dallas | Texas | 75235 | — |
| Pfizer Investigational Site | Dallas | Texas | 75390-8590 | — |
| Pfizer Investigational Site | Dallas | Texas | 75390-9015 | — |
| Pfizer Investigational Site | Richardson | Texas | 75080 | — |
| Pfizer Investigational Site | Trophy Club | Texas | 76262 | — |
| Pfizer Investigational Site | Bountiful | Utah | 84010 | — |
| Pfizer Investigational Site | Layton | Utah | 84041 | — |
| Pfizer Investigational Site | Murray | Utah | 84107 | — |
| Pfizer Investigational Site | Provo | Utah | 84604 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84106 | — |
| Pfizer Investigational Site | WVC | Utah | 84120 | — |
| Pfizer Investigational Site | Burlington | Vermont | 05401 | — |
| Pfizer Investigational Site | Everett | Washington | 98201 | — |
| Pfizer Investigational Site | Kennewick | Washington | 99336 | — |
| Pfizer Investigational Site | Richland | Washington | 99352 | — |
| Pfizer Investigational Site | Madison | Wisconsin | 53792-5666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00254891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00254891 live on ClinicalTrials.gov.